Ironwood Pharmaceuticals, Inc.
IRWD
$3.58
-$0.09-2.45%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 102.18M | 24.02M | 28.55M | -7.89M | -32.34M |
| Total Depreciation and Amortization | 1.85M | 1.88M | 1.91M | 1.94M | 1.98M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.42M | 61.50M | 105.06M | 89.58M | 92.83M |
| Change in Net Operating Assets | -70.23M | 39.65M | -67.83M | -53.65M | 16.06M |
| Cash from Operations | 112.21M | 127.04M | 67.68M | 29.99M | 78.52M |
| Capital Expenditure | -3.00K | -34.00K | -35.00K | -49.00K | -105.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.00K | -34.00K | -35.00K | -49.00K | -105.00K |
| Total Debt Issued | -- | -- | 0.00 | 0.00 | 150.00M |
| Total Debt Repaid | -- | -- | -15.00M | -40.00M | -240.00M |
| Issuance of Common Stock | 210.00K | 216.00K | 297.00K | 297.00K | 958.00K |
| Repurchase of Common Stock | -- | -- | 0.00 | 0.00 | -121.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -90.00K | -2.25M | -2.25M |
| Cash from Financing | 210.00K | 216.00K | -14.79M | -41.95M | -91.41M |
| Foreign Exchange rate Adjustments | -428.00K | -329.00K | -659.00K | -659.00K | -63.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 111.99M | 126.90M | 52.20M | -12.67M | -13.06M |